Banco BBVA Perú (BVL:BBVAC1)

Verve Therapeutics Balance Sheet

Financials in millions PEN. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,947	10,288	6,060	6,354	14,564	23,064
Investment Securities	11,687	11,354	10,767	8,325	5,014	6,704
Trading Asset Securities	5,391	5,111	5,625	4,632	5,973	5,724
Total Investments	17,078	16,466	16,392	12,957	10,987	12,428
Gross Loans	77,271	77,749	74,899	73,188	74,550	70,576
Allowance for Loan Losses	-4,050	-4,157	-4,899	-4,663	-4,658	-4,419
Net Loans	73,221	73,592	70,001	68,525	69,891	66,156
Property, Plant & Equipment	1,160	1,202	1,193	1,078	1,071	1,013
Other Intangible Assets	422.07	434.3	399.09	378.06	318.91	285.34
Accrued Interest Receivable	495.99	526.07	646.38	596.97	542.16	437.29
Other Receivables	1,909	946.39	732.77	285.12	228.85	221.37
Restricted Cash	4,760	3,263	3,372	5,791	1,731	1,890
Other Current Assets	312.41	316.5	302.96	261.32	225.76	354.69
Long-Term Deferred Tax Assets	794.36	814.12	786.86	774.05	710.09	685.33
Other Real Estate Owned & Foreclosed	41.03	58.81	118.78	67.87	43.92	34.3
Other Long-Term Assets	1,922	3,281	4,320	976.76	1,181	767.25
Total Assets	108,062	111,189	104,324	98,045	101,496	107,337
Accounts Payable	1,088	1,066	1,019	878.4	469.93	361.87
Accrued Expenses	783.2	854.54	672.27	632.03	480.85	416.68
Interest Bearing Deposits	50,803	52,568	46,916	43,814	38,729	41,922
Non-Interest Bearing Deposits	27,359	27,650	23,810	23,087	25,360	30,291
Total Deposits	78,162	80,218	70,727	66,902	64,088	72,213
Short-Term Borrowings	2,268	3,777	8,324	11,854	17,824	16,654
Current Portion of Long-Term Debt	901.87	118.11	955.94	607.48	3,068	803.25
Accrued Interest Payable	48.54	69.65	114.15	74.02	25.27	61.14
Other Current Liabilities	4,108	3,834	4,531	1,805	976.7	1,175
Long-Term Debt	7,080	7,238	4,951	3,429	3,772	5,744
Long-Term Unearned Revenue	71.42	74.21	75.33	77.1	74.71	74.52
Other Long-Term Liabilities	633.46	638.88	584.25	532.75	546.78	472.25
Total Liabilities	95,145	97,889	91,954	86,792	91,327	97,975
Common Stock	9,649	8,895	8,147	7,382	6,758	6,529
Retained Earnings	3,157	4,320	4,115	3,962	3,443	2,714
Comprehensive Income & Other	111.04	85.37	107.41	-91.05	-32.7	119.15
Shareholders' Equity	12,918	13,300	12,370	11,253	10,169	9,362
Total Liabilities & Equity	108,062	111,189	104,324	98,045	101,496	107,337
Total Debt	10,250	11,134	14,231	15,891	24,665	23,201
Net Cash (Debt)	1,089	4,266	-2,547	-4,905	-4,127	5,587
Net Cash Growth	-	-	-	-	-	124.20%
Net Cash Per Share	0.11	0.44	-0.26	-0.51	-0.43	0.58
Filing Date Shares Outstanding	9,649	9,649	9,649	9,649	9,649	9,649
Total Common Shares Outstanding	9,649	9,649	9,649	9,649	9,649	9,649
Book Value Per Share	1.34	1.38	1.28	1.17	1.05	0.97
Tangible Book Value	12,495	12,866	11,971	10,875	9,850	9,077
Tangible Book Value Per Share	1.29	1.33	1.24	1.13	1.02	0.94

Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.